Advertisement
Screener

XTL BIOPHARMACEUTICALS LTD. (XTLB) Form 6-K: Report of foreign private issuer, 2018

XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2018-12-27: Form 6-K; Period of report 2018-12-27; Description REPORT OF FOREIGN PRIVATE ISSUER; Document f6k122718_xtlbiopharm.htm.
  • 2018-12-20: Form 6-K; Period of report 2018-12-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document f6k122018_xtlbiopharma.htm.
  • 2018-11-15: Form 6-K; Period of report 2018-11-15; Description REPORT OF FOREIGN PRIVATE ISSUER; Document f6k111518_xtlbiopharma.htm.
  • 2018-11-08: Form 6-K; Period of report 2018-11-08; Description REPORT OF FOREIGN PRIVATE ISSUER; Document f6k110818_xtlbiopharma.htm.
FiledFormPeriod of reportDescriptionDocument
2018-12-276-K2018-12-27REPORT OF FOREIGN PRIVATE ISSUERf6k122718_xtlbiopharm.htm
2018-12-206-K2018-12-20REPORT OF FOREIGN PRIVATE ISSUERf6k122018_xtlbiopharma.htm
2018-11-156-K2018-11-15REPORT OF FOREIGN PRIVATE ISSUERf6k111518_xtlbiopharma.htm
2018-11-086-K2018-11-08REPORT OF FOREIGN PRIVATE ISSUERf6k110818_xtlbiopharma.htm
2018-11-016-K2018-11-01REPORT OF FOREIGN PRIVATE ISSUERf6k110118_xtlbiopharma.htm
2018-07-246-K2018-07-24REPORT OF FOREIGN PRIVATE ISSUERf6k072418_xtlbiopharma.htm
2018-05-306-K2018-05-29REPORT OF FOREIGN PRIVATE ISSUERf6k052918_xtlbiopharma.htm
2018-05-226-K2018-05-22CURRENT REPORT OF FOREIGN ISSUERf6k052218_xtlbiopharm.htm
2018-05-156-K2018-05-15REPORT OF FOREIGN PRIVATE ISSUERf6k051518_xtlbiopharmac.htm
2018-04-106-K2018-04-10REPORT OF FOREIGN PRIVATE ISSUERf6k041018_xtlbiopharma.htm